Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06289179

Thyroid and Cortisol Hormone Response to Sepsis

Thyroid and cortisol hormone response to sepsis

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

About this study

Sepsis is dysregulated host response to infection that results in life-threatening organ dysfunction. Virtually every body system can be affected by this syndrome to greater or lesser extents.

Endocrine alterations are well characterised in sepsis with variations in circulating blood levels and/or receptor resistance.

In response to any psychological or physical stressor, there is widespread neurohormonal activation to adapt body with the stressor. Production and secretion of stress hormones increase to modulate behaviour Many studies have been performed investigating specific hormonal perturbations such as critical illness-induced corticosteroid insufficiency ,all of which are associated with worse outcomes and poor of body inflammation. However, the endocrine system as a whole has been largely overlooked as a fundamental contributor to the integrated host response to sepsis thyroid axis is affected during sepsis with decreased pituitary release of thyroid stimulating hormone (TSH) and inhibition of the peripheral conversion of thyroxine (T4) by 5-deiodinase to the much more metabolically active triiodothyronine (T3). High cortisol levels also inhibit this enzymatic conversion.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The study will include Adults (≥18 years), both genders
  • septic patients admitted to critical care unit

Exclusion criteria

  • thyroid disease
  • hypopituitarism
  • Addison disease
  • Cushing syndrome)

Treatment and study plan

Primary outcomes

  1. Pattern of cortisol level and thyroid function response to sepsis in ICU

    Time frame: From time of admission to ICU up to 3rd day after discharge

    Affect of sepsis on hormones at ICU:compare the change of endocrinal hormones ( TSH (mIU/L) .T3(ng/dL) .T4 ( mcg/dL) adrenocorticotropic hormone "ACTH" (pg/mL) , cortisol (µg/dL)) at time of admission, course ICU ,3rd day after discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed Hossam Aldin Hassan, Professor

CONTACT

[email protected]

01006261166

Sara Mahmoud khalf allah Mohamed

CONTACT

[email protected]

01099929480

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Thyroid and Cortisol Hormone Response in Patients With Sepsis Who Attended To Assiut University Hospitals (ICU)

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Mar 1, 2024
Registry last updated
Mar 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.